The US Supreme Court has temporarily restored broad access to mifepristone, a commonly used abortion pill, after a federal appeals court ruled on Friday to restrict its availability by mail and via telehealth prescriptions. The Supreme Court's intervention pauses that ruling while it further considers the case, which could have sweeping implications for abortion access across the country. The back-to-back rulings have reignited a politically charged debate ahead of this year's midterm elections, with abortion rights advocates hoping to mobilise voters and some anti-abortion groups warning that Republican voters may stay home if the Trump administration fails to pursue stricter restrictions on the drug.